​

Fusion Pharmaceuticals Ownership | Who Owns Fusion Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Fusion Pharmaceuticals Ownership Summary

Fusion Pharmaceuticals is owned by 94.52% institutional investors, and 5.48% retail investors. First trust capital management is the largest institutional shareholder, holding 0% of FUSN shares. Federated Hermes Kaufmann R is the top mutual fund, with 6.44% of its assets in Fusion Pharmaceuticals shares.

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
First trust capital management---
Geode capital management---
Voya investment management---
Proshare advisors---
Pentwater capital management lp---
Yakira capital management---
Atika capital management---
Legal & general group---
Toth financial advisory---
Gabelli funds---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
First trust capital management---
Geode capital management---
Voya investment management---
Proshare advisors---
Pentwater capital management lp---
Yakira capital management---
Atika capital management---
Legal & general group---
Toth financial advisory---
Gabelli funds---

Top Buyers

HolderShares% AssetsChange
Scarborough advisors---13.00
Gamma investing---26.00
Fny investment advisers---85.00
Advisor group---86.00
Daiwa securities group---268.00

Top Sellers

HolderShares% AssetsChange
Federated hermes---10.81M
Perceptive advisors---6.83M
Avidity partners management lp---6.50M
Deerfield management company, l.p. (series c)---6.40M
Fil---4.19M

Sold Out

HolderChange
Scarborough advisors-13.00
Gamma investing-26.00
Fny investment advisers-85.00
Advisor group-86.00
Daiwa securities group-268.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202414068.67%69,088,92913.64%941.22%9566.67%1362.50%
Dec 31, 202383112.82%60,795,56021.84%881.55%57375.00%8-
Sep 30, 202339-2.50%49,899,434-0.71%750.86%12-25.00%860.00%
Jun 30, 20234011.11%50,257,17810.27%931.30%16-11.11%525.00%
Mar 31, 20233620.00%45,577,70160.64%842.11%18125.00%433.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Federated Hermes Kaufmann R5.48M6.44%-
Federated Hermes Kaufmann Growth5.48M6.44%-
Federated Hermes Kaufmann Small Cap Grow5.07M5.97%-
Federated Hermes Kaufmann Small Cap A5.07M5.97%-
Fidelity Canadian Large Cap Sr B2.55M3.00%2.55M
Fidelity Canadian Large Cp Mlt Ast Bs O1.74M2.05%80.00K
Fidelity Concntr Val Priv Pool Sr F479.45K0.56%479.45K
Fidelity Monthly Income Series F418.71K0.49%418.71K
Fidelity Global Equity+ Fund - F381.14K0.45%221.25K
MEDICAL BioHealth EUR Acc308.00K0.36%308.00K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--
2023 Q2--

FUSN Ownership FAQ

Who owns the most shares of Fusion Pharmaceuticals?

Fusion Pharmaceuticals’s largest shareholders are First trust capital management (0 shares, 0%), Geode capital management (0 shares, 0%), and Voya investment management (0 shares, 0%). Together, they hold 0% of Fusion Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fusion Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Fusion Pharmaceuticals.

Who is Fusion Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

First trust capital management is Fusion Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Fusion Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Fusion Pharmaceuticals shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Fusion Pharmaceuticals shares, with 6.44% of its total shares outstanding invested in 5.48M Fusion Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools